Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Rheumatoid Arthritis, Systemic Juvenile 1 Rectal Neoplasms 1 Primary Myelofibrosis 1 Periodic Fevers Syndrome 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mevalonate Kinase Deficiency 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Melanoma 1 Leukemia, Myelomonocytic, Chronic 1 Intestinal Neoplasms 1 Gastrointestinal Neoplasms 1 Cryopyrin-Associated Periodic Syndromes 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Clonal Cytopenia of Undetermined Significance 1 Carcinoma, Renal Cell 1 Carcinoma, Ductal 1 Carcinoma 1 Bronchiolitis Obliterans Syndrome 1 Breast Neoplasms 1 Arthritis, Juvenile 1 Arthralgia 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

Nivolumab 143 pembrolizumab 129 Sunitinib 127 Bevacizumab 71 Everolimus 70 Sorafenib 68 cabozantinib 64 Ipilimumab 61 pazopanib 58 Axitinib 57 aldesleukin 51 Magnetic Resonance Spectroscopy 43 Cyclophosphamide 40 Interleukin-2 38 lenvatinib 36 Radiosurgery 36 Specimen Handling 33 Interferon-alpha 32 atezolizumab 29 belzutifan 24 temsirolimus 23 Gemcitabine 23 fludarabine phosphate 22 Radiotherapy 18 Interferon alpha-2 18 Biopsy 18 fludarabine 17 durvalumab 17 avelumab 17 Paclitaxel 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Renal Cell × canakinumab × Clear all

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡